Fangning Wan

2.7k total citations · 1 hit paper
78 papers, 2.1k citations indexed

About

Fangning Wan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Fangning Wan has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 31 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Fangning Wan's work include Renal cell carcinoma treatment (17 papers), Prostate Cancer Treatment and Research (17 papers) and Cancer, Lipids, and Metabolism (15 papers). Fangning Wan is often cited by papers focused on Renal cell carcinoma treatment (17 papers), Prostate Cancer Treatment and Research (17 papers) and Cancer, Lipids, and Metabolism (15 papers). Fangning Wan collaborates with scholars based in China, United States and Japan. Fangning Wan's co-authors include Dingwei Ye, Yao Zhu, Wenhao Xu, Bo Dai, Bo Dai, Hailiang Zhang, Guohai Shi, Yunjie Yang, Jiashu Sun and Baoquan Ding and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Fangning Wan

77 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers

2019 394 citations Fangning Wan, Yunjie Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fangning Wan China	24	1.2k	774	767	422	255	78	2.1k
Mikael Johansson Sweden	20	826 0.7×	449 0.6×	619 0.8×	483 1.1×	215 0.8×	44	1.8k
Rosalie Nolley United States	23	814 0.7×	1.0k 1.3×	400 0.5×	317 0.8×	174 0.7×	55	2.0k
Ingeborg Tinhofer Germany	26	872 0.7×	629 0.8×	848 1.1×	1.4k 3.4×	169 0.7×	77	2.5k
Anli Yang China	24	917 0.8×	325 0.4×	780 1.0×	381 0.9×	105 0.4×	71	1.6k
Viive M. Howell Australia	26	852 0.7×	418 0.5×	568 0.7×	672 1.6×	163 0.6×	74	2.2k
Ruth Board United Kingdom	23	732 0.6×	441 0.6×	656 0.9×	1.0k 2.4×	214 0.8×	57	1.9k
Bungo Furusato United States	26	1.1k 0.9×	1.4k 1.8×	618 0.8×	759 1.8×	185 0.7×	63	2.7k
Jens Köllermann Germany	27	1.0k 0.8×	1.4k 1.8×	513 0.7×	667 1.6×	389 1.5×	116	2.7k
Attila Marcell Szász Hungary	24	594 0.5×	306 0.4×	420 0.5×	611 1.4×	236 0.9×	127	1.7k
Laura Muinelo‐Romay Spain	28	966 0.8×	384 0.5×	1.0k 1.4×	846 2.0×	80 0.3×	81	2.0k

Countries citing papers authored by Fangning Wan

Since Specialization

Citations

This map shows the geographic impact of Fangning Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangning Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangning Wan more than expected).

Fields of papers citing papers by Fangning Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangning Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangning Wan. The network helps show where Fangning Wan may publish in the future.

Co-authorship network of co-authors of Fangning Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Fangning Wan. A scholar is included among the top collaborators of Fangning Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangning Wan. Fangning Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abudurexiti, Mierxiati, et al.. (2025). FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner. npj Precision Oncology. 9(1). 127–127. 4 indexed citations

Zhu, Yanhui, Jing Ma, Fangning Wan, et al.. (2025). Development of a questionnaire to evaluate the management of gestational diabetes mellitus patients among obstetric nurses. Frontiers in Public Health. 13. 1521673–1521673.

Li, Junhong, et al.. (2024). Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide. Oncogene. 43(10). 744–757. 9 indexed citations

Duan, Lewei, Zheng Liu, Fangning Wan, & Bo Dai. (2024). Advantage of whole-mount histopathology in prostate cancer: current applications and future prospects. BMC Cancer. 24(1). 448–448. 2 indexed citations

Liu, Shiwei, Junhong Li, Junyu Zhang, et al.. (2024). IKBKE regulates renal cell carcinoma progression and sunitinib resistance through the RRM2-AKT pathway. International Journal of Biological Sciences. 20(15). 6146–6161. 1 indexed citations

Li, Junhong, et al.. (2023). Targeting SMYD2 inhibits prostate cancer cell growth by regulating c‐Myc signaling. Molecular Carcinogenesis. 62(7). 940–950. 10 indexed citations

Dai, Bo, Fangning Wan, Hongkai Wang, et al.. (2022). Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial. European Urology Oncology. 5(5). 519–525. 38 indexed citations

Luo, Wenjie, Jun Wang, Wenhao Xu, et al.. (2021). LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death and Disease. 12(11). 1043–1043. 131 indexed citations

Yu, Wei, Yingjian Zhang, Xiaoping Xu, et al.. (2020). A Prospective Trial of 68Ga-PSMA and 18F-FDG PET/CT in Nonmetastatic Prostate Cancer Patients with an Early PSA Progression During Castration. Clinical Cancer Research. 26(17). 4551–4558. 49 indexed citations

10.

Abudurexiti, Mierxiati, Wenkai Zhu, Jun Wang, et al.. (2020). Targeting CPT1B as a potential therapeutic strategy in castration‐resistant and enzalutamide‐resistant prostate cancer. The Prostate. 80(12). 950–961. 40 indexed citations

11.

Wu, Jie, Yu-Chen Wang, Wenhao Xu, et al.. (2020). <p>High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 10453–10464. 15 indexed citations

12.

Shao, Ning, Hong Tang, Yuanyuan Qu, Fangning Wan, & Dingwei Ye. (2019). Development and validation of lncRNAs-based nomogram for prediction of biochemical recurrence in prostate cancer by bioinformatics analysis. Journal of Cancer. 10(13). 2927–2934. 12 indexed citations

13.

Xu, Wenhao, Yuanyuan Qu, Jun Wang, et al.. (2019). Elevated CD36 expression correlates with increased visceral adipose tissue and predicts poor prognosis in ccRCC patients. Journal of Cancer. 10(19). 4522–4531. 32 indexed citations

14.

Xie, Huyang, Yiping Zhu, Guohai Shi, et al.. (2019). Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer. Frontiers in Oncology. 9. 856–856. 16 indexed citations

15.

Wan, Fangning, Haoyue Sheng, Yiping Zhu, et al.. (2018). Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis. Scientific Reports. 8(1). 374–374. 9 indexed citations

16.

Qin, Xiao-Jian, Yuan-Yuan Qu, Yu Zhu, et al.. (2016). Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients. Medicine. 95(27). e4066–e4066. 13 indexed citations

17.

Wan, Fangning, Lei Xu, Naiqing Zhao, et al.. (2015). Is it Safe to Omit Baseline Bone Scan for Newly Diagnosed Prostate Cancer Patients?. Urologia Internationalis. 94(3). 342–346. 6 indexed citations

18.

Qin, Xiaojian, Hailiang Zhang, Fangning Wan, et al.. (2015). Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study. World Journal of Surgical Oncology. 13(1). 132–132. 5 indexed citations

19.

Lü, Xiaolin, Fangning Wan, Hai‐Liang Zhang, Guohai Shi, & Dingwei Ye. (2015). ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Tumor Biology. 37(1). 253–262. 35 indexed citations

20.

Wan, Fangning, Yao Zhu, Chengyuan Gu, et al.. (2014). Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer. World Journal of Surgical Oncology. 12(1). 14–14. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact